- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.07. | Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar | ||
| 10.07. | Apertura and NIH institutes to test gene therapy for NPC1 | ||
| 09.07. | Moderna secures up to 24 million RSV vaccine dose contract with Europe | ||
| 09.07. | Sino and AstraZeneca sign licence agreement for TQC3721 | ||
| 09.07. | Evogene and Tel Aviv University launch drug discovery initiative | ||
| 08.07. | FDA cracks down on illegal ketamine sellers amid nearing 'psychedelic revolution' | ||
| 08.07. | Kalohexis confidentially files IPO to back obesity and cachexia portfolio | ||
| 08.07. | Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant | ||
| 08.07. | FDA grants rare paediatric designation to Vanda's CMT2S therapy | ||
| 08.07. | Biocytogen and Whitehawk partner to develop ADCs | ||
| 07.07. | Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline | ||
| 07.07. | Vertex signs agreement to acquire Crinetics for $10bn | ||
| 07.07. | EC approves AbbVie's Tepkinly combination for follicular lymphoma | ||
| 06.07. | UK biotechs struggling to access finance as scale-up concerns grow | ||
| 06.07. | Novartis to acquire Myricx Bio in up to $1.5bn deal | ||
| 06.07. | Roche pens $490m Astex breast cancer license deal | ||
| 06.07. | Besins Healthcare boosts drug delivery portfolio with UniD deal | ||
| 03.07. | WHO intensifies Ebola-curbing efforts through drug trial and diagnostic rollout | ||
| 03.07. | US-UK pharma trade deal paints a costly economic picture for NHS | ||
| 03.07. | SK bioscience to lead Gates Foundation-funded ROTOR project | ||
| 03.07. | European Commission approves Novartis' Itvisma to treat SMA | ||
| 02.07. | Ipsen bolsters rare disease pipeline in €700m Memo takeover | ||
| 02.07. | FDA widens Vertex's Casgevy use for paediatric patients | ||
| 02.07. | Insilico Medicine, Takeda partner on AI-driven drug discovery | ||
| 02.07. | Inocras, AimedBio team up for cancer treatments |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.